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Introduction
Cardiovascular magnetic resonance imaging (CMR)
allows for accurate assessment of structure and function
with high spatial resolution. Although the use of CMR has
been well established in Europe, not much information is
available for the extent of this emerging imaging modality
in Canada.
Purpose
This single-centre study sought to summarize indications,
safety, imaging quality, extent of contrast use, and extent
of stress tests performed.
Methods
Retrospective analysis was performed on 5165 patients
scanned from July 2005 - September 2009 at the CMR
Centre.
Results
The mean age of the patients was 50 +/- 17; range 9 to 100
years old. The most common clinical indications were
myocarditis/cardiomyopathies (2004; 38.8%), coronary
artery disease/ischemic heart disease (749; 14.5%),
arrhythmogenic right-ventricular dysplasia and/or other
right ventricular disease (560; 10.8%), and pulmonary
vein anatomy (212; 4.1%). The indications for the
remaining cases included: cardiac mass, pericardial dis-
ease, thrombus, congenital cases, and valvular disease.
Gadolinium-based contrast agent was given to 97% of
patients as part of their CMR protocol. Of the 10.1%
(494/5165) patients that underwent stress CMR, adenos-
ine was administered in 94.3% of cases and dobutamine
was administered in 5.7% of cases. 1/466 patients
(0.21%) suffered ventricular tachycardia during adenos-
ine stress and transient, asymptomatic AV block was occa-
sionally observed. Moderate to severe complications after
contrast agent administration occurred in 8/5001
(0.16%) contrast-enhanced studies, characterized by nau-
sea and vomiting in six (0.11%) patients and by symp-
toms of acute systemic allergic reaction in 2 (0.04%)
patients. Image quality was good in 82.8%, moderate in
16.3%, and non-diagnostic in 1.0% of cases.
Conclusion
In the high-volume CMR centre, the main clinical indica-
tions were for myocarditis/cardiomyopathies, coronary
artery disease/ischemic heart disease, and right-ventricu-
lar related queries. The safety of CMR was extremely high
and diagnostic image quality was achieved in 99% of
cases. In high-volume centres, CMR serves as a robust, safe
and efficient modality.
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